Search Results

Coast to Coast Hundreds Climb over 1,000 Steps to End Blood Cancer

Coast to Coast Hundreds Climb over , Steps to End Blood Cancer

Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask

What is my actual diagnosis? Find out your exact diagnosis. Ask your doctor to write down the exact name of your and take the paper with you. For exa…

Understanding the drug resistance mechanism and developing new therapeutic strategies for Hairy Cell Leukemia variant

Most of the Hairy Cell Leukemia variant patients do not respond to conventional therapies. They develop resistance to the chemotherapy drugs and we wi…

The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New Members

RYE BROOK, NY, July , - The Leukemia & Lymphoma Society (LLS) announced today National Board Officer appointments and four new members to its Nationa…

People with CLL are living longer than ever before, and cures are on the horizon

People with the most common type of blood cancer, chronic lymphocytic leukemia (CLL), are living longer than ever before without their disease progres…

The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes

FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease

This week marked another milestone for the treatment of graft versus host disease in children. The U.S. Food and Drug Administration (FDA) approved ib…

Leveraging Susceptible Populations and Unique Resources in a Pathway to Prevention of Childhood Acute Lymphoblastic Leukemia

The focus of my research is to understand the causes and origins of acute lymphoblastic leukemia (ALL). We use a approach: ) conducting epidemiologi…

FDA Approves New Treatment Option For Chronic Graft-Versus-Host-Disease In Patients Ages 12 Years And Older

RYE BROOK, N.Y., August , - The U.S. Food and Drug Administration (FDA) recently approved belumosudil (Rezurock™) in patients years or older for the…

Mosunetuzumab with lenalidomide augmentation as first-line therapy for patients with follicular and marginal zone lymphoma

Dr. Olszewski’s trial will examine mosunetuzumab as a treatment for follicular and marginal zone lymphomas— types of lymphoma which remain incurable…

Suggested Reading - Chicken Soup for the Surviving Soul: 101 Healing Stories About Those Who Have Survived Cancer

More than cancer survivors share their personal stories in this touching new collection of Chicken Soup. These heartwarming accounts of courageous pe…

Suggested Reading - Four Walls: Breaking Through Life’s Challenges, One Wall at a Time: A Memoir of Battling Cancer

All of the blood in Ryan Scanlan’s body is someone else’s. At years old, Ryan was diagnosed with a blood cancer called acute myeloid leukemia. Despit…

Additional resources for young adults

As a young adult with cancer, you will likely face challenges specific to your age group. We are here to help. Materials to order or downloadSurvivors…

Where Blood Cancer Meets Nature: Why This Scholarship Recipient Is Saving the Earth

When we think about the future, a lot can feel uncertain—especially as a teenager or young adult (AYA) with blood cancer. We get it. The AYA crowd f…

Bob Ross-Inspired “America’s Most Artistic Kid” Competition Shines a Light on Blood Cancer United

Blood Cancer United is honored to be the beneficiary of this year’s America’s Most Artistic Kid competition, presented by Bob Ross Inc. and Colossal, …

America’s Most Beautiful Bike Ride Unites Cyclists Against Blood Cancer in Lake Tahoe

America’s Most Beautiful Bike Ride Unites Cyclists Against Blood Cancer in Lake Tahoe

Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment

In collaboration with AVEO Oncology, an LG Chem company, (“AVEO”) the new Beat AML is evaluating ficlatuzumab, a monoclonal antibody targeting hepato…

High School Students Kick off Philanthropic Competition to Help All Blood Cancer Patients

WASHINGTON, Jan.

Nearly 60% of Blood Cancer Patients Covered By Medicare Delay or Forgo Treatment

View full multimedia release here. Highlights of Milliman Study on Medicare treatment costs…

Celebrating Diversity Fueled High School Students to Break Fundraising Records for Cancer Cures

(RYE BROOK, NY, July , ) - The effects of the pandemic are far reaching, and high school students are among those whose lives are being . Not only is…

Hematopoietic Cell Transplantation as Treatment for Blood Cancers: The Team Approach - For Nurses

For Nurses and Advanced Practice Providers

Blood Cancer United Selected as MPN Research Foundation’s Exclusive Clinical Trial Navigation Partner

Partnership Designed to Enhance & Improve Clinical Trial Navigation Experience for Patients with Rare Blood Cancers

FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type

The Leukemia & Lymphoma Society has provided funding to research that identified novel ways to attack the IDH mutation in patients with blood cancers.…

Cycling Enthusiasts to Embark on One-of-a-Kind Adventure to Support Blood Cancer Patients Nationwide

The Leukemia & Lymphoma Society’s Picturesque Scenic Shore Bike Tour on Lake Michigan Shoreline offers a Unique Ride Experience to Help Drive its Life…

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

RYE BROOK, N.Y., December , – The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of five scientific invest…